[1]张园园,王天宇,白建豪,等.肠道微生物群与年龄相关性黄斑变性相关性的研究进展[J].眼科新进展,2022,42(6):491-494.[doi:10.13389/j.cnki.rao.2022.0100]
　ZHANG Yuanyuan,WANG Tianyu,BAI Jianhao,et al.Recent advances in the correlation between intestinal microbiota and age-related macular degeneration[J].Recent Advances in Ophthalmology,2022,42(6):491-494.[doi:10.13389/j.cnki.rao.2022.0100]
点击复制

肠道微生物群与年龄相关性黄斑变性相关性的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
42卷
期数:
2022年6期
页码:
491-494
栏目:
文献综述
出版日期:
2022-06-05

文章信息/Info

Title:
Recent advances in the correlation between intestinal microbiota and age-related macular degeneration
作者:
张园园; 王天宇; 白建豪; 薛雅文; 彭清
200331　上海市， 同济大学医学院（张园园，王天宇，白建豪，薛雅文，彭清）；200072　上海市，同济大学附属第十人民医院眼科（张园园，王天宇，白建豪，薛雅文，彭清）
Author(s):
ZHANG Yuanyuan1; 2; WANG Tianyu1; 2; BAI Jianhao1; 2; XUE Yawen1; 2; PENG Qing1; 2
1.School of Medicine, Tongji University， Shanghai 200331, China
2.Department of Ophthalmology, Shanghai Tenth People’s Hospital, Shanghai 200072, China
关键词:
年龄相关性黄斑变性; 肠道微生物群; 菌群失调
Keywords:
age-related macular degeneration;  intestinal microbiota;  dysbacteriosis
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2022.0100
文献标志码:
A
摘要:
年龄相关性黄斑变性（AMD）是严重影响视力的一种眼底疾病，其病因与发病机制尚未明确，可能与环境因素、代谢和遗传等因素相关。目前，有研究表明，肠道微生物群直接或间接与AMD相关。因此，检测和调控人体的肠道微生物群可能会为AMD的诊断和治疗提供新的诊疗思维。本文汇总了近年来相关研究，并对预防和治疗AMD的可能诊治方法，如粪便微生物移植、补充益生元和益生菌、饮食调整及抗生素和免疫球蛋白治疗进行概述。
Abstract:
Age-related macular degeneration (AMD) is a fundus disease that seriously affects vision. Its etiology and pathogenesis are not clear, but may be related to environment, metabolism, and genetics. At present, studies have shown that intestinal microbiota is directly or indirectly related to AMD. Therefore, the detection and regulation of human intestinal microbiota may provide new ideas for diagnosis and treatment of AMD. This paper summarizes the relevant research in recent years and outlines the possible methods for the prevention and treatment of AMD, such as fecal microbial transplantation, probiotic supplement, diet adjustment, antibiotics, and immunoglobulin.

参考文献/References:

［1］　MITCHELL P,LIEW G,GOPINATH B,WONG T Y.Age-related macular degeneration［J］.Lancet,2018,392(10153):1147-1159.
［2］　CHEN M,XU H.Parainflammation,chronic inflammation,and age-related macular degeneration［J］.J Leukoc Biol,2015,98(5):713-725.
［3］　LYNCH S V,PEDERSEN O.The human intestinal microbiome in health and disease［J］.N Engl J Med,2016,375(24):2369-2379.
［4］　ANDEWEG S P,KE MIR C,DUTILH B E.Quantifying the impact of human leukocyte antigen on the human gut microbiota［J］.mSphere,2021,6(4):e0047621.
［5］　HILLS R D Jr,PONTEFRACT B A,MISHCON H R,BLACK C A,SUTTON S C,THEBERGE C R.Gut microbiome:profound implications for diet and disease［J］.Nutrients,2019,11(7):1613.
［6］　KHO Z Y,LAL S K.The human gut microbiome-a potential controller of wellness and disease［J］.Front Microbiol,2018,9:1835.
［7］　CHAUDHARI S N,MCCURRY M D,DEVLIN A S.Chains of evidence from correlations to causal molecules in microbiome-linked diseases［J］.Nat Chem Biol,2021,17(10):1046-1056.
［8］　RAUSCH P,RHLEMANN M,HERMES B M,DOMS S,DAGAN T,DIERKING K,et al.Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms［J］.Microbiome,2019,7(1):133.
［9］　KUGADAS A,WRIGHT Q,GEDDES-MCALISTER J,GADJEVA M.Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA［J］.Invest Ophthalmol Vis Sci,2017,58(11):4593-4600.
［10］　LIN P.The role of the intestinal microbiome in ocular inflammatory disease［J］.Curr Opin Ophthalmol,2018,29(3):261-266.
［11］　SCHROEDER B O,BCKHED F.Signals from the gut microbiota to distant organs in physiology and disease［J］.Nat Med,2016,22(10):1079-1089.
［12］　ADAMS M K,SIMPSON J A,AUNG K Z,MAKEYEVA G A,GILES G G,ENGLISH D R,et al.Abdominal obesity and age-related macular degeneration［J］.Am J Epidemiol,2011,173(11):1246-1255.
［13］　NAGAI N,KAWASHIMA H,TODA E,HOMMA K,OSADA H,GUZMAN N A,et al.Renin-angiotensin system impairs macrophage lipid metabolism to promote age-related macular degeneration in mouse models［J］.Commun Biol,2020,3(1):767.
［14］　ANDRIESSEN E M,WILSON A M,MAWAMBO G,DEJDA A,MILOUDI K,SENNLAUB F,et al.Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization［J］.EMBO Mol Med,2016,8(12):1366-1379.
［15］　BEYAZ S,MANA M D,ROPER J,KEDRIN D,SAADATPOUR A,HONG S J,et al.High-fat diet enhances stemness and tumorigenicity of intestinal progenitors［J］.Nature,2016,531(7592):53-58.
［16］　ZELANTE T,IANNITTI R G,CUNHA C,DE LUCA A,GIOVANNINI G,PIERACCINI G,et al.Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22［J］.Immunity,2013,39(2):372-385.
［17］　DO M H,LEE E,OH M J,KIM Y,PARK H Y.High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change［J］.Nutrients,2018,10(6):761.
［18］　CHOUDHARY M,KAZMIN D,HU P,THOMAS R S,MCDONNELL D P,MALEK G.Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways［J］.J Pathol,2015,235(1):101-112.
［19］　TAO Y,HE M,YANG Q,MA Z,QU Y,CHEN W,et al.Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments［J］.Drug Des Devel Ther,2019,13:2689-2702.
［20］　BISWAS L,IBRAHIM K S,LI X,ZHOU X,ZENG Z,CRAFT J,et al.Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice,implication for age-related macular degeneration［J］.Exp Eye Res,2021,208:108625.
［21］　ACAR I E,LORES-MOTTA L,COLIJN J M,MEESTER-SMOOR M A,VERZIJDEN T,COUGNARD-GREGOIRE A,et al.Integrating metabolomics,genomics,and disease pathways in age-related macular degeneration:the eye-risk consortium［J］.Ophthalmology,2020,127(12):1693-1709.
［22］　CHANG G,MA N,ZHANG H,WANG Y,HUANG J,LIU J,et al.Sodium butyrate modulates mucosal inflammation injury mediated by gpr41/43 in the cecum of goats fed a high concentration diet［J］.Front Physiol,2019,10:1130.
［23］　LIN P.Importance of the intestinal microbiota in ocular inflammatory diseases:a review［J］.Clin Exp Ophthalmol,2019,47(3):418-422.
［24］　LIU A,CHANG J,LIN Y,SHEN Z,BERNSTEIN P S.Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration［J］.J Lipid Res,2010,51(11):3217-3229.
［25］　MIYAMOTO J,MIZUKURE T,PARK S B,KISHINO S,KIMURA I,HIRANO K,et al.A gut microbial metabolite of linoleic acid,10-hydroxy-cis-12-octadecenoic acid,ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway［J］.J Biol Chem,2015,290(5):2902-2918.
［26］　COHEN L J,ESTERHAZY D,KIM S H,LEMETRE C,AGUILAR R R,GORDON E A,et al.Commensal bacteria make GPCR ligands that mimic human signalling molecules［J］.Nature,2017,549(7670):48-53.
［27］　TERAO R,HONJO M,AIHARA M.Apolipoprotein M inhibits angiogenic and inflammatory response by sphingosine 1-phosphate on retinal pigment epithelium cells［J］.Int J Mol Sci,2017,19(1):112.
［28］　TERAO R,HONJO M,UETA T,OBINATA H,IZUMI T,KURANO M,et al.Light stress-induced increase of sphingosine 1-phosphate in photoreceptors and its relevance to retinal degeneration［J］.Int J Mol Sci,2019,20(15):3670.
［29］　FERNNDEZ-SNCHEZ L,LAX P,PINILLA I,MARTN-NIETO J,CUENCA N.Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats［J］.Invest Ophthalmol Vis Sci,2011,52(8):4998-5008.
［30］　ALHASANI R H,ALMARHOUN M,ZHOU X,REILLY J,PATTERSON S,ZENG Z,et al.Tauroursodeoxycholic acid protects retinal pigment epithelial cells from oxidative injury and endoplasmic reticulum stress in vitro［J］.Biomedicines,2020,8(9):367.
［31］　WANG C F,YUAN J R,QIN D,GU J F,ZHAO B J,ZHANG L,et al.Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats［J］.J Ethnopharmacol,2016,185:162-170.
［32］　MAHARJAN P,KIM D,JIN M,KO H J,SONG Y H,LEE Y,et al.Preclinical evaluation of udca-containing oral formulation in mice for the treatment of wet age-related macular degeneration［J］.Pharmaceutics,2019,11(11):561.
［33］　MALSY J,ALVARADO A C,LAMONTAGNE J O,STRITTMATTER K,MARNEROS A G.Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization［J］.Elife,2020,9:e60194.
［34］　CHEN L,QING W,YI Z,LIN G,PENG Q,ZHOU F.NU9056,a KAT 5 inhibitor,treatment alleviates brain dysfunction by inhibiting NLRP3 inflammasome activation,affecting gut microbiota,and derived metabolites in LPS-treated mice［J］.Front Nutr,2021,8:701760.
［35］　ZYSSET-BURRI D C,KELLER I,BERGER L E,LARGIADR C R,WITTWER M,WOLF S,et al.Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration［J］.NPJ Genom Med,2020,5:34.
［36］　CHENG Y W,PHELPS E,GANAPINI V,KHAN N,OUYANG F,XU H,et al.Fecal microbiota transplantation for the treatment of recurrent and severe clostridium difficile infection in solid organ transplant recipients:a multicenter experience［J］.Am J Transplant,2019,19(2):501-511.
［37］　VRIEZE A,VAN NOOD E,HOLLEMAN F,SALOJRVI J,KOOTTE R S,BARTELSMAN J F,et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome［J］.Gastroenterology,2012,143(4):913-916.
［38］　MORITA Y,JOUNAI K,SAKAMOTO A,TOMITA Y,SUGIHARA Y,SUZUKI H,et al.Long-term intake of lactobacillus paracasei KW3110 prevents age-related chronic inflammation and retinal cell loss in physiologically aged mice［J］.Aging (Albany NY),2018,10(10):2723-2740.
［39］　VERMA A,XU K,DU T,ZHU P,LIANG Z,LIAO S,et al.Expression of human ace2 in lactobacillus and beneficial effects in diabetic retinopathy in mice［J］.Mol Ther Methods Clin Dev,2019,14:161-170.
［40］　FU Z,LIEGL R,WANG Z,GONG Y,LIU C H,SUN Y,et al.Adiponectin mediates dietary omega-3 long-chain polyunsaturated fatty acid protection against choroidal neovascularization in mice［J］.Invest Ophthalmol Vis Sci,2017,58(10):3862-3870.
［41］　GONG Y,FU Z,EDIN M L,LIU C H,WANG Z,SHAO Z,et al.Cytochrome P450 oxidase 2C inhibition adds to ω-3 long-chain polyunsaturated fatty acids protection against retinal and choroidal neovascularization［J］.Arterioscler Thromb Vasc Biol,2016,36(9):1919-1927.
［42］　DONALDSON G P,LADINSKY M S,YU K B,SANDERS J G,YOO B B,CHOU W C,et al.Gut microbiota utilize immunoglobulin A for mucosal colonization［J］.Science,2018,360(6390):795-800.
［43］　OKAI S,USUI F,YOKOTA S,HORI I Y,HASEGAWA M,NAKAMURA T,et al.High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice［J］.Nat Microbiol,2016,1(9):16103.

相似文献/References:

[1]范姜砾 王雨生 张鹏.湿性年龄相关性黄斑变性患者血浆中相关抗氧化酶水平测定[J].眼科新进展,2012,32(5):000.
[2]王毅 李罗翔 李娟 曾庆华.ApoE基因缺失小鼠视网膜及Bruch膜组织形态观察[J].眼科新进展,2013,33(1):000.
[3]徐新荣 仲路 黄冰林 魏源华 周欣 王玲 王富强.年龄相关性黄斑变性血浆蛋白质组学初步研究[J].眼科新进展,2013,33(2):000.
[4]党亚龙 陈彬川 穆雅林 赵满丽 朱豫.i-MP对产生2型脉络膜新生血管的年龄相关性黄斑变性患者视力及黄斑厚度的影响[J].眼科新进展,2013,33(2):000.
[5]王毅 李罗翔 李进辉 李娟 曾庆华.血脂异常ApoE基因缺失小鼠视网膜色素上皮细胞胞浆内黑色素和脂褐素的改变[J].眼科新进展,2013,33(7):000.
[6]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[7]陆秉文 吴星伟.光动力疗法治疗年龄相关性黄斑变性的研究进展[J].眼科新进展,2013,33(4):000.
[8]栾兰 姚勇.湿性年龄相关性黄斑变性的治疗进展[J].眼科新进展,2013,33(4):000.
[9]胡艳红 祁明信 郭娜 陈胜 柯发杰.渗出型年龄相关性黄斑变性患者外周血CCR3的表达[J].眼科新进展,2013,33(11):000.
[10]金鑫,张红.MicroRNA在年龄相关性黄斑变性发病中的作用[J].眼科新进展,2014,34(8):787.[doi:10.13389/j.cnki.rao.2014.0218]
　JIN Xin,ZHANG Hong.Role of microRNA in pathogenesis of agerelated macular degeneration[J].Recent Advances in Ophthalmology,2014,34(6):787.[doi:10.13389/j.cnki.rao.2014.0218]

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81470029）；《促进市级医院临床技能与临床创新三年行动计划》关键支撑项目（编号：SHDC2020CR5014）
更新日期/Last Update: 2022-06-05